Eris Lifesciences Ltd
NSE:ERIS
Wall Street
Price Targets
ERIS Price Targets Summary
Eris Lifesciences Ltd
According to Wall Street analysts, the average 1-year price target for
ERIS
is 1 079.87 INR
with a low forecast of 919.1 INR and a high forecast of 1 291.5 INR.
Operating Income
Forecast
Operating Income Estimate
Eris Lifesciences Ltd
For the last 8 years the
compound annual growth rate for
Eris Lifesciences Ltd's operating income is
19%.
The projected
CAGR
for the next 4 years is
26%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ERIS's stock price target?
Price Target
1 079.87
INR
According to Wall Street analysts, the average 1-year price target for
ERIS
is 1 079.87 INR
with a low forecast of 919.1 INR and a high forecast of 1 291.5 INR.
What is Eris Lifesciences Ltd's Revenue forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Eris Lifesciences Ltd's revenue is
15%.
The projected
CAGR
for the next 4 years is
21%.
What is Eris Lifesciences Ltd's Operating Income forecast?
Projected CAGR
26%
For the last 8 years the
compound annual growth rate for
Eris Lifesciences Ltd's operating income is
19%.
The projected
CAGR
for the next 4 years is
26%.
What is Eris Lifesciences Ltd's Net Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Eris Lifesciences Ltd's net income is
20%.
The projected
CAGR
for the next 4 years is
16%.
You don't have any saved screeners yet
